Free account + included starter software — credential review typically takes 1–2 business days. See how it works
NDC 16729-0132-12

QUETIAPINE FUMARATE 50 mg/1 TABLET, EXTENDED RELEASE

Accord Healthcare Inc.

In Stock at Premier Pharma
NDC
16729-0132-12
Generic Name
QUETIAPINE FUMARATE
Brand Name
QUETIAPINE FUMARATE
Strength
50 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Package Size
Labeler
Accord Healthcare Inc.

FDA Drug Information

Indications & Usage

1 INDICATIONS AND USAGE Quetiapine Extended-release tablet is an atypical antipsychotic indicated for the treatment of: Schizophrenia (1.1) Bipolar I disorder, manic, or mixed episodes (1.2) Bipolar disorder, depressive episodes (1.2) Major depressive disorder, adjunctive therapy with antidepressants (1.3) 1.1 Schizophrenia Quetiapine Extended-release tablets are indicated for the treatment of schizophrenia. The efficacy of quetiapine extended-release tablets in schizophrenia was established in…

Source: FDA. For professional use only. Not a substitute for prescribing information.

Order NDC 16729-0132-12 at Wholesale

Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).